Ignite Creation Date:
2024-05-06 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03130881
Status:
UNKNOWN
Last Update Posted:
2020-03-04
First Post:
2017-04-19
Brief Title:
Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK NSCLC
Sponsor:
Beijing Pearl Biotechnology Limited Liability Company
Organization:
Beijing Pearl Biotechnology Limited Liability Company
Organization Data
Organization:
Beijing Pearl Biotechnology Limited Liability Company
Class:
INDUSTRY
Study ID:
HMO-PLB1003-20160828
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Pearl Biotechnology Limited Liability Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None